期刊文献+

~99Tc^m-MDP骨显像结合PSA测定诊断前列腺癌及其骨转移的临床价值 被引量:5

下载PDF
导出
摘要 前列腺癌发病隐匿,临床症状少见,测定血清总前列腺特异抗原(TPSA,T)和游离前列腺特异抗原(FPSA,F)水平,并计算F/T比值,是诊断前列腺癌的重要指标.^99Tc^m-亚甲基二膦酸盐(MDP)骨显像是探测恶性肿瘤骨转移的灵敏方法,两者结合应用对诊断前列腺癌及其骨转移有重要价值.笔者对此进行了研究,现报道如下.
出处 《中华核医学杂志》 CAS CSCD 北大核心 2006年第5期312-313,共2页 Chinese Journal of Nuclear Medicine
  • 相关文献

参考文献7

二级参考文献27

  • 1韩伟明.-[J].日用化学工业,1987,(3):31-31.
  • 2姜义娟.-[J].日用化学工业,1986,(3):27-27.
  • 3[3]WolffJM, Ittel TH, Boeckmann W, et al. Metastatic workup of patients with prostate cancer employing skeletal alkaline phosphatase [J]. Anticancer Res, 1997,17 (4B):2995-2997.
  • 4[5]Puig S, Staudenherz A, Steiner B, et al. Differential diagnosis of a typically located single or double hot spots in whole bone scaning[J]. J Nucl Med, 1998, 39:1263-1266.
  • 5[10]Reale MG, Santini D, Marchei GG, et al. Skeletal alkaline phosphatase as a serum marker of bone metastases in the follow up of patients with breast canser [J]. Int J Biol Markers, 1995, 10(1):42-46.
  • 6谷现恩,现代前列腺疾病,1997年,118页
  • 7Franks JA, Ling A, Patronas NJ, et al. Detection of malignant bone tumors: MR imaging vs scintigraphy. Am J Roentgenol, 1990, 155:1043-1048.
  • 8Wagnar HN. Highlights 2001 lecture: against all odds, nuclear medicine has thiven. J Nucl Med, 2001, 42: 12-30.
  • 9Israel O, Keidar Z, losilevsky G, et al. The fusion of anatomic and physiologic imaging in the management of patients with cancer. Semin Nucl Med, 2001, 31 : 192-205.
  • 10Resnick D. Degenerative diseases of the vertebral column. Radiology,1985, 156: 3-14.

共引文献103

同被引文献41

  • 1范义湘,罗荣城,李贵平,黄凯.骨显像联合碱性磷酸酶诊断159例前列腺癌骨转移[J].肿瘤学杂志,2004,10(5):340-342. 被引量:4
  • 2谢红军,匡安仁.^(99m)TC-MDP全身骨显像165例前列腺癌骨转移的分析[J].四川医学,2005,26(11):1215-1216. 被引量:13
  • 3朱广文,张延军,杜雪梅,陶莉,解静慧,胡伟.~99Tc^m-MDP SPECT/CT骨显像诊断恶性肿瘤骨转移的价值[J].中华核医学杂志,2005,25(6):335-336. 被引量:53
  • 4Coleman RE.Metastatic bone disease:clinieal features,pathophysiology and treatment strategies[J].Cancer Treat Rev,2001,27(3):165-176.
  • 5陈昭典 韦思明 蔡松良.前列腺特异抗原在前列腺癌早期诊断的应用.中国泌尿外科杂志,2002,23(9):558-559.
  • 6Wymenga L,Boomsma J,Groenier K,et al.Routine bone scans in patients with prostate cancer related to serum prostate-specific antigen and alkaline phosphatase[J].BJU Int,2001,88(3):226-230.
  • 7Fang N,Li Y,Xu YS,et al.Serum concentrations of IL-2 and TNF-alpha in patients with painful bone metastases:correlation with responses to 89SRC12 therapy[J].J Nucl Med,2006 47(2):242-246.
  • 8Stamey TA.Some comments on progress in the standardization of immunoassays for prostate-spocific antigen[J].Br J Urol,1999,79 (Suppl 1):49.
  • 9Smith R A,Cokkinides V,Eyre H J.Cancer screening in the Unit-ed States 2007:a review of current guidelines,practices,and pros-pects[J].CA Cancer J Clin,2007,57:90-104.
  • 10Abrahamsson P A,Tinzl M.Do we need PSA and early detection ofprostate cancer?[J].Eur Urol Suppl,2008,7:393-395.

引证文献5

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部